Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | A4GALT | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | ABCA13 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-06 |
mRNA | ABCC9 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.004 |
mRNA | ABHD3 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
mRNA | ABI1 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
mRNA | ABI3BP | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
mRNA | ABO | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
mRNA | AC002398.9 | CTRPv2 | pan-cancer | AAC | -0.14 | 8e-05 |
mRNA | AC002985.3 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
mRNA | AC007192.4 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |